NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
| | | | | |

NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence

On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…